AKT1 and urinary bladder cancer: The integrated analysis of 131 muscle-invasive bladder cancer specimens reveals that dysregulation of PI3K/Akt pathway is detected in 72% of the tumours26, hence regulatory elements of the PI3K/Akt pathway have received much attention as potential therapeutic targets 38.